Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2019-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Well Biotech. It provides a summary of the audit opinion, consolidated and separate financial statements, and key financial metrics for the fiscal year ending 2018-12-31. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report to the regulator (KRX), rather than the full, multi-page annual report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2018
2019-03-19 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) titled '유상증자 또는 주식관련사채 등의 발행결과' (Result of issuance of paid-in capital increase or stock-related bonds). It details the final outcome of a capital increase (share issuance), including the number of shares issued and the total amount raised. This falls under the category of share issuance and capital changes.
2019-03-14 Korean
기타경영사항(자율공시)
Audit Report / Information Classification · 95% confidence The document is a short regulatory announcement (under 1,000 characters) from Wellbiotech regarding the delay in the submission of their audit report. It does not contain the audit report itself, but rather serves as a notification of a delay in regulatory filing requirements. As it is a general regulatory announcement regarding corporate disclosure status, it fits best under the RNS (Regulatory Filings) category. FY 2018
2019-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (주주총회소집공고) for WellBiotec Co., Ltd. It details the meeting agenda, including amendments to the articles of incorporation, appointment of an auditor, and stock option grants. This document is provided to shareholders to inform them of the meeting and request their participation/votes. According to the provided definitions, this falls under 'Proxy Solicitation & Information Statement' (PSI), as it contains the necessary information for shareholders to make informed voting decisions at the upcoming meeting.
2019-03-06 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees and directors, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a regulatory filing under the RNS category, as it does not fit into specific categories like DIRS (which is for personal trades) or SHA (which is for general share issuance).
2019-03-06 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for WellBiotec Co., Ltd. It contains the meeting agenda, details on board activities, and financial statements (balance sheet, income statement, etc.) for the 44th fiscal year. In the context of Korean regulatory filings (DART), this document is a 'Proxy Solicitation & Information Statement' (PSI) because it provides shareholders with the necessary information to vote on agenda items at the upcoming general meeting.
2019-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.